The Swiss cosmetics manufacturer Galderma achieved year-on-year sales of 3.76 billion US dollars in 2022. According to the company, this represents an increase of 13.9 per cent compared to the previous year. In particular, the Injectable Aesthetics and Dermatological Skincare segments posted significant increases of 22.3 per cent and 30.7 per cent, respectively, which the company said was primarily driven by volume growth. Further information …